Correlation Between BNP Paribas and Abionyx Pharma

Can any of the company-specific risk be diversified away by investing in both BNP Paribas and Abionyx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BNP Paribas and Abionyx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BNP Paribas SA and Abionyx Pharma SA, you can compare the effects of market volatilities on BNP Paribas and Abionyx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BNP Paribas with a short position of Abionyx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BNP Paribas and Abionyx Pharma.

Diversification Opportunities for BNP Paribas and Abionyx Pharma

-0.34

Correlation Coefficient

BNP Paribas  Abionyx Pharma

Very good diversification

The 3 months correlation between BNP and Abionyx is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding BNP Paribas SA and Abionyx Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abionyx Pharma SA and BNP Paribas is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BNP Paribas SA are associated (or correlated) with Abionyx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abionyx Pharma SA has no effect on the direction of BNP Paribas i.e., BNP Paribas and Abionyx Pharma go up and down completely randomly.

Pair Corralation between BNP Paribas and Abionyx Pharma

Assuming the 90 days trading horizon BNP Paribas SA is expected to under-perform the Abionyx Pharma. But the stock apears to be less risky and, when comparing its historical volatility, BNP Paribas SA is 2.03 times less risky than Abionyx Pharma. The stock trades about -0.06 of its potential returns per unit of risk. The Abionyx Pharma SA is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  123.00  in Abionyx Pharma SA on October 7, 2024 and sell it today you would lose (2.00) from holding Abionyx Pharma SA or give up 1.63% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BNP Paribas SA  vs.  Abionyx Pharma SA

BNP Paribas SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BNP Paribas SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, BNP Paribas is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Abionyx Pharma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Abionyx Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Abionyx Pharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with BNP Paribas and Abionyx Pharma

The main advantage of trading using opposite BNP Paribas and Abionyx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BNP Paribas position performs unexpectedly, Abionyx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abionyx Pharma will offset losses from the drop in Abionyx Pharma's long position.

The idea behind BNP Paribas SA and Abionyx Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.